Jamie B. Scaglione
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jamie B. Scaglione has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Adam J. Kanack
Department of Laboratory Medicine & Pathology Mayo Clinic Rochester Minnesota USA
1 shared publication - Brian Christopher Smith
Department of Biochemistry, Medical College of Wisconsin, Milwaukee, USA
1 shared publication - David Gooden
Small Molecule Synthesis Facility, Duke University, Durham, North Carolina 27708, USA
1 shared publication - Kenneth Matthew Scaglione
Duke University
1 shared publication Kevin McMahon
Department of Computational and Physical Sciences Carroll University Waukesha WI 53186 USA
1 shared publication- Michael D. Olp
Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
1 shared publication
Latest Publications
- Open Access
- 3 February 2022
- Published by Wiley in ChemBioChem
- Vol. 23 (6) , e202100633
Chemical Regulation of the Protein Quality Control E3 Ubiquitin Ligase C‐Terminus of Hsc70 Interacting Protein (CHIP)
The ubiquitin ligase C‐terminus of Hsc70 interacting protein (CHIP) is an important regulator of proteostasis. Despite playing an important role in maintaining proteostasis, little progress has been made in developing small molecules that regulate ubiquitin transfer by CHIP. Here we used differential scanning fluorimetry to identify compounds that bound CHIP. Compounds that bound CHIP were then analyzed by quantitative ubiquitination assays to identify those that altered CHIP function. One compound, MS.001, inhibited both the chaperone binding and ubiquitin ligase activity of CHIP at low micromolar concentrations. Interestingly, we found that MS.001 did not have activity against isolated U‐box or tetratricopeptide (TPR) domains, but instead only inhibited full‐length CHIP. Using in silico docking we identified a potential MS.001 binding site on the linker domain of CHIP and mutation of this site rendered CHIP resistant to MS.001. Together our data identify an inhibitor of the E3 ligase CHIP and provides insight into the development of compounds that regulate CHIP activity.
- 3 February 2022
- Published by Wiley in ChemBioChem
- Vol. 23 (6) , e202100633
Open AccessChemical Regulation of the Protein Quality Control E3 Ubiquitin Ligase C‐Terminus of Hsc70 Interacting Protein (CHIP)
The ubiquitin ligase C‐terminus of Hsc70 interacting protein (CHIP) is an important regulator of proteostasis. Despite playing an important role in maintaining proteostasis, little progress has been made in developing small molecules that regulate ubiquitin transfer by CHIP. Here we used differential scanning fluorimetry to identify compounds that bound CHIP. Compounds that bound CHIP were then analyzed by quantitative ubiquitination assays to identify those that altered CHIP function. One compound, MS.001, inhibited both the chaperone binding and ubiquitin ligase activity of CHIP at low micromolar concentrations. Interestingly, we found that MS.001 did not have activity against isolated U‐box or tetratricopeptide (TPR) domains, but instead only inhibited full‐length CHIP. Using in silico docking we identified a potential MS.001 binding site on the linker domain of CHIP and mutation of this site rendered CHIP resistant to MS.001. Together our data identify an inhibitor of the E3 ligase CHIP and provides insight into the development of compounds that regulate CHIP activity.